Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer-Reference-Cited by-同舟云学术

Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer

Published:2022-05 Issue: Volume:122 Page:105708
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Nafie Mohamed S.,Boraei Ahmed T.A.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference43 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA;Sung;CA Cancer J Clin.,2021

2. Design, synthesis, and molecular docking of novel indole scaffold-based VEGFR-2 inhibitors as targeted anticancer agents;Roaiah;Archiv Der Pharmazie.,2018

3. Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy;Takahashi;Biol Pharm Bull.,2011

4. Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the antiproliferative activity of anti-hormones;Liang;Endocr Relat Cancer.,2006

5. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies;Shibuya;Genes & Cancer.,2011

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural modification strategies of triazoles in anticancer drug development;European Journal of Medicinal Chemistry;2024-09

2. Design, synthesis and molecular docking of 5-fluoro indole derivatives as inhibitors of PI3K/Akt signalling pathway in cervical cancer;Journal of Molecular Structure;2024-09

3. Pyrrole-containing hybrids as potential anticancer agents: An insight into current developments and structure-activity relationships;European Journal of Medicinal Chemistry;2024-07

4. Synthesis of novel cyanopyridine compounds as potential EGFR inhibitors targeting A549 and PC3 cancer cell lines: In vitro, In vivo and ADME pharmacokinetics studies;Journal of Molecular Structure;2024-06

5. Recent advances on quinoxalines as target‐oriented chemotherapeutic anticancer agents through apoptosis;Archiv der Pharmazie;2024-05-31